Top compounds associated with response to MARCH10


Feature Type Standardized
Nominal ANOVA
mRNA JNK Inhibitor VIII GDSC1000 pan-cancer AAC 0.061 0.07
mRNA ML006 CTRPv2 pan-cancer AAC -0.066 0.07
mRNA MS-275 gCSI pan-cancer AAC 0.097 0.07
mRNA Bleomycin CTRPv2 pan-cancer AAC -0.067 0.07
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.06 0.08
mRNA Doxorubicin CTRPv2 pan-cancer AAC -0.052 0.08
mRNA UNC0638 GDSC1000 pan-cancer AAC 0.051 0.08
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.052 0.08
mRNA Sildenafil CTRPv2 pan-cancer AAC 0.066 0.08
mRNA GW-405833 CTRPv2 pan-cancer AAC -0.059 0.08
Download CSV